Peter Krisper

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus‐infected acute‐on‐chronic liver failure treated by entercavir: A prospective study

Molecular mediators of hepatic steatosis and liver injury

Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity

Pathogenesis of Hepatorenal Syndrome: Implications for Therapy

Albumin–drug interaction and its clinical implication

Severe mitral annular calcification predicts chronic kidney disease

Low Antioxidant Status of Serum Uric Acid, Bilirubin, Albumin, and Creatinine in Patients With Benign Paroxysmal Positional Vertigo

Acute-on chronic liver failure

Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas

Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis

Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases

Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure

Peroxisomal Lipid Degradation via β and β-oxidation in Mammals

Peroxisomal Bifunctional Protein Deficiency Revisited: Resolution of Its True Enzymatic and Molecular Basis

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

Fatal Dialysis Vascular Access Hemorrhage

Plasma Dia-Filtration for Severe Sepsis

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson's disease

Biosynthesis of the Caenorhabditis elegans dauer pheromone

The Enzymes, Regulation, and Genetics of Bile Acid Synthesis

Severe Cholestasis and Bile Cast Nephropathy Induced by Anabolic Steroids Successfully Treated with Plasma Exchange

PEROXISOMALβ-OXIDATION ANDPEROXISOMEPROLIFERATOR–ACTIVATEDRECEPTORα: An Adaptive Metabolic System

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update

Molecular mediators of hepatic steatosis and liver injury

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas

Oxidative albumin damage in chronic liver failure: Relation to albumin binding capacity, liver dysfunction and survival

Clearing of toxic substances: are there differences between the available liver support devices?

cDNA Cloning of the Human Peroxisomal Enoyl-CoA Hydratase: 3-Hydroxyacyl-CoA Dehydrogenase Bifunctional Enzyme and Localization to Chromosome 3q26.3-3q28: A Free Left Alu Arm Is Inserted in the 3′ Noncoding Region

Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease

Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure

In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation

Technology Insight: artificial extracorporeal liver support—how does Prometheus® compare with MARS®?

Prevalence of Detectable Venous Pressure Drops Expected with Venous Needle Dislodgement